Your questions.
Clear answers.
Get to know the collection, the science and how to request product information.
About the collection.
Product roles, documentation and availability.
View all questionsHow do the four products differ?
PRIME focuses on antioxidant and hydration preparation. SIGNAL combines FGF FUSION + IGF FUSION. PDGF MATRIX is a PDGF-BB matrix-binding development concept. BARRIER focuses on postbiotic care.
How can I request pricing or availability?
Send a professional inquiry with your organization, country and product of interest. TheraGene can confirm current availability, product status and commercial information.
Where can I find ingredients, storage and directions?
Ask TheraGene for the current product information and applicable label. Product-specific documentation governs ingredients, preparation, storage and permitted use.
Is PDGF MATRIX currently in development?
Yes. PDGF MATRIX is presented as a development concept. Published preclinical research supports the underlying matrix-affinity rationale; it does not establish clinical superiority for Epi-Glo PDGF MATRIX.
Your questions.
Clear answers.
Get to know the product concept, the science, and the thinking behind Epi-Glo.
What is Epi-Glo PDGF MATRIX?
PDGF MATRIX is TheraGene’s development concept for recombinant PDGF-BB incorporating a PlGF-derived extracellular-matrix-binding domain. It extends the Epi-Glo family with a focus on matrix affinity.
What does “matrix binding” mean?
The extracellular matrix is the network surrounding cells. The PDGF MATRIX design includes a domain selected for its ability to associate with matrix proteins. The aim is improved local retention; finished-product behavior still requires product-specific evaluation.
Does “PlGF-derived” mean the product contains placenta?
PlGF is the abbreviation for placental growth factor. Here, the term describes the biological origin of a binding-domain design. It does not mean the product is a placental extract or is designed to bind to placenta.
Is PDGF MATRIX proven to be better than other PDGF products?
No head-to-head human study establishing Epi-Glo PDGF MATRIX’s superiority is presented here. The distinction is its proposed molecular design. Published preclinical work supports the technology rationale; it does not establish Epi-Glo clinical results.
How does PDGF MATRIX fit with PRIME, SIGNAL and BARRIER?
PRIME focuses on preparation, SIGNAL on FGF FUSION + IGF FUSION, and BARRIER on postbiotic care. PDGF MATRIX is a distinct PDGF-BB development direction. Contact TheraGene to discuss which product and documentation fit your needs.
Can I order PDGF MATRIX or request technical information?
Please contact TheraGene for current development status, availability, specifications and permitted uses. Request product information ↗.
Is Epi-Glo for injection or application after a procedure?
Epi-Glo topical products are not for injection or ophthalmic use. Suitability for any specific application, including use following a procedure, must follow the applicable product label and supporting product-specific data. This site does not provide a treatment protocol.
Are the women pictured actual patients?
The portraits are original illustrative campaign imagery. They are not patient testimonials, before-and-after photographs, or evidence of product results.
Let’s make
a connection.
Ask TheraGene about Epi-Glo, current availability, product information or partnership opportunities.